Skip to main content
Premium Trial:

Request an Annual Quote

Digital Gene Names Former Investment Banker Vice-President

Premium

LA JOLLA, Calif.--Digital Gene Technologies, a total gene expression and comparison company here, announced that it has appointed Andrew Schwab as vice-president of business development to coordinate the company's business development activities and institutional investor relations.

Schwab came from the investbanking firm NationsBanc Montgomery Securities, where he was vice-president of the firm's health care group.

Cellomics Receives $1 Million Grant From National Cancer Institute PITTSBURGH--Cellomics, a privately held company founded here in 1996, received a component of a five year $4.2 million program project grant from the National Cancer Institute Special Emphasis Panel, the company announced. Cellomics' project, entitled Combinatorial Approaches for Novel Anticancer Agents, will receive approximately $1 million of the grant. Led by John Lazo, chairman of the University of Pittsburgh School of Medicine pharmacology department and a member of the Cellomics scientific advisory board, the project's goal is to generate novel chemical libraries based on potent, natural product-derived pharmacophores and to identify promising new lead structures that affect cancer relevant molecular targets.

Cellomics will design and implement high-content screening approaches to screen the combinatorial libraries of anticancer drugs that will be synthesized throughout the program project. Molecular and synthetic fluorescent reagents will be employed in high-content screening of a variety of potential targets. Cellomics' ArrayScan System will serve as the platform for both the fixed and live cell assays designed to screen the combinatorial libraries of anticancer lead compounds.

Filed under